C M Bidwell & Associates LTD Regenxbio Inc. Transaction History

C M Bidwell & Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$19.35 - $35.04 $134,676 - $243,878	-6,960 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$24.62 - $34.31 $64,873 - $90,406	2,635 Added 60.92%	6,960 $231,000
Q4 2021 Feb 11, 2022	BUY	$30.19 - $40.28 $130,571 - $174,211	4,325 New	4,325 $141,000
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $25,472 - $40,704	-800 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$42.0 - $59.29 $22,470 - $31,720	-535 Reduced 40.07%	800 $41,000
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $54,494 - $83,370	1,335 New	1,335 $77,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $416M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.